Europe Aquatic Veterinary Market Size and Forecast (2021

Description

List of Tables

The Europe Aquatic Veterinary Market is projected to grow significantly, reaching an estimated US$ 557.5 million by 2031, up from US$ 439.0 million in 2024. This growth represents a compound annual growth rate (CAGR) of 3.5% from 2025 to 2031.

Executive Summary and Market Analysis

The European aquatic veterinary market encompasses several key countries, including the UK, Germany, France, Italy, and Spain, among others. This region is witnessing steady growth driven primarily by the increasing consumer demand for seafood and products derived from aquatic animals. The expansion of Europe's aquaculture sector is a significant contributor to this trend, as it enhances the supply of fish and other aquatic species. Furthermore, there is a notable rise in investments directed towards research, particularly in the development of vaccines for fish, which plays a crucial role in improving disease management and farming conditions.

In April 2021, the European Union introduced a pivotal regulation concerning animal health, aimed at modernizing and simplifying the management of aquatic animal health. This regulation mandates EU member states to formulate multi-year plans that focus on sustainable aquaculture practices. The new guidelines emphasize the reduction of antibiotic usage, the adoption of smarter farming techniques, and preparedness for health risks associated with climate change and emerging diseases. Collectively, these factors create a robust foundation for the continued advancement of the aquatic veterinary market across Europe.

Strategic Insights

Market Segmentation Analysis

The Europe Aquatic Veterinary Market can be segmented based on various criteria:

By Type: The market is divided into Diagnostic and Treatment segments, with the Treatment segment leading in 2024.
By Diagnostic Type: This includes Serological, Molecular Diagnosis, DNA Sequencing, and other diagnostic methods, where Molecular Diagnosis was the dominant segment in 2024.
By Treatment Type: The Treatment segment is further categorized into Vaccines, Medications, and Supplements, with Medications holding the largest share in 2024.
By Species: The market is segmented into Fish, Crustaceans, Mollusca, and others, with Fish being the predominant category in 2024.
By Disease Source: This includes Bacterial, Viral, Parasites, and others, where Bacterial diseases were the most significant segment in 2024.
By Route of Administration: The market is segmented into Water Medication, Medicated Feed, and other routes, with Water Medication being the leading method in 2024.

Market Outlook

Aquatic animals such as fish, crabs, mussels, and lobsters are increasingly consumed by humans, leading to a surge in seafood demand. This demand is propelling the aquaculture industry forward. Fish, in particular, are recognized for their rich nutritional content, including essential vitamins, proteins, fatty acids, and minerals, making them a vital source of omega-3 fatty acids. Research has linked omega-3 fatty acids to numerous health benefits, including a reduced risk of heart disease, prevention of childhood asthma and depression, and enhanced brain health. According to the Organization for Economic Cooperation and Development (OECD), global fish production is expected to reach 200 million metric tons by 2029, with approximately 90% of this production intended for human consumption.

Crabs also contribute significantly to the aquatic food supply, being rich in proteins and essential nutrients while containing low levels of saturated fats. Their consumption is associated with various health benefits, including improved joint and heart health. The increasing global demand for aquatic animals is driving production growth; for instance, crab production in Russia rose from 86.3 thousand metric tons in 2017 to 93.3 thousand metric tons in 2020.

As seafood consumption rises, there is a corresponding need for high-quality produce, which necessitates the provision of proper nutrients and feeds. This demand is met through the administration of vaccines and supplements, further propelling the aquatic veterinary market.

Country Insights

The Europe Aquatic Veterinary Market is also analyzed by country, with significant contributions from the United Kingdom, Germany, France, Spain, Italy, and the Rest of Europe. Germany, in particular, held the largest market share in 2024.

The growth of the aquatic veterinary market in Germany is attributed to ongoing advancements in the aquaculture and fishery sectors. The country hosts numerous aquaculture businesses focused on species such as rainbow trout, common carp, and mussels. In 2021, approximately 18,300 metric tons of fish were produced in Germany by around 2,200 aquaculture enterprises. Notably, mussel production increased by 5.8% to reach approximately 14,300 metric tons in the same year. The rising fish production and heightened awareness of fish health during cultivation are key factors driving market growth in Germany.

In January 2022, a collaborative research initiative between the German Society for Marine Aquaculture and the Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering was launched, aimed at enhancing aquaculture practices and promoting innovative technologies. Such developments are expected to further strengthen the aquatic veterinary market in Germany.

Company Profiles

Key players in the Europe Aquatic Veterinary Market include Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Virbac SA, Phibro Animal Health Corp., HIPRA SA, Indian Immunologicals Ltd., Esox Biologics Ltd., Ceva Polchem Pvt Ltd., and Aquatic Diagnostics Ltd. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative solutions to their customers.

Product Code: TIPRE00042714

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:

4. Aquatic Veterinary Market Landscape

4.1 Market Overview
4.2 PEST Analysis

5. Europe Aquatic Veterinary Market - Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:

6. Aquatic Veterinary Market - Europe Market Analysis

6.1 Europe Aquatic Veterinary Market Revenue (US$ Million), 2024 - 2031
6.2 Europe Aquatic Veterinary Market Forecast and Analysis

7. Europe Aquatic Veterinary Market Revenue Analysis - by Type

7.1 Diagnostic
- 7.1.1 Overview
- 7.1.2 Diagnostic: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Treatment
- 7.2.1 Overview
- 7.2.2 Treatment: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

8. Europe Aquatic Veterinary Market Revenue Analysis - by Diagnostic Type

8.1 Serological
- 8.1.1 Overview
- 8.1.2 Serological: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Molecular Diagnosis
- 8.2.1 Overview
- 8.2.2 Molecular Diagnosis: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 DNA Sequencing
- 8.3.1 Overview
- 8.3.2 DNA Sequencing: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Other Diagnostics
- 8.4.1 Overview
- 8.4.2 Other Diagnostics: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9. Europe Aquatic Veterinary Market Revenue Analysis - by Treatment Type

9.1 Vaccines
- 9.1.1 Overview
- 9.1.2 Vaccines: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Medications
- 9.2.1 Overview
- 9.2.2 Medications: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Supplements
- 9.3.1 Overview
- 9.3.2 Supplements: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

10. Europe Aquatic Veterinary Market Revenue Analysis - by Species

10.1 Fish
- 10.1.1 Overview
- 10.1.2 Fish: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Crustaceans
- 10.2.1 Overview
- 10.2.2 Crustaceans: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Mollusca
- 10.3.1 Overview
- 10.3.2 Mollusca: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Others
- 10.4.1 Overview
- 10.4.2 Others: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

11. Europe Aquatic Veterinary Market Revenue Analysis - by Diseases Source

11.1 Bacterial
- 11.1.1 Overview
- 11.1.2 Bacterial: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Viral
- 11.2.1 Overview
- 11.2.2 Viral: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3 Parasites
- 11.3.1 Overview
- 11.3.2 Parasites: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.4 Others
- 11.4.1 Overview
- 11.4.2 Others: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

12. Europe Aquatic Veterinary Market Revenue Analysis - by Route of Administration

12.1 Water Medication
- 12.1.1 Overview
- 12.1.2 Water Medication: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Medicated Feed
- 12.2.1 Overview
- 12.2.2 Medicated Feed: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Other Route of Administrations
- 12.3.1 Overview
- 12.3.2 Other Route of Administrations: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

13. Europe Aquatic Veterinary Market - Country Analysis

13.1 Europe
- 13.1.1 Europe Aquatic Veterinary Market Revenue and Forecast and Analysis - by Country
  - 13.1.1.1 Europe Aquatic Veterinary Market Revenue and Forecast and Analysis - by Country
  - 13.1.2.2 United Kingdom: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.1.2.2.1 United Kingdom: Europe Aquatic Veterinary Market Share - by Type
    - 13.1.2.2.2 United Kingdom: Europe Aquatic Veterinary Market Share - by Diagnostic Type
    - 13.1.2.2.3 United Kingdom: Europe Aquatic Veterinary Market Share - by Treatment Type
    - 13.1.2.2.4 United Kingdom: Europe Aquatic Veterinary Market Share - by Species
    - 13.1.2.2.5 United Kingdom: Europe Aquatic Veterinary Market Share - by Diseases Source
    - 13.1.2.2.6 United Kingdom: Europe Aquatic Veterinary Market Share - by Route Of Administration
  - 13.2.3.3 Germany: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.2.3.3.1 Germany: Europe Aquatic Veterinary Market Share - by Type
    - 13.2.3.3.2 Germany: Europe Aquatic Veterinary Market Share - by Diagnostic Type
    - 13.2.3.3.3 Germany: Europe Aquatic Veterinary Market Share - by Treatment Type
    - 13.2.3.3.4 Germany: Europe Aquatic Veterinary Market Share - by Species
    - 13.2.3.3.5 Germany: Europe Aquatic Veterinary Market Share - by Diseases Source
    - 13.2.3.3.6 Germany: Europe Aquatic Veterinary Market Share - by Route Of Administration
  - 13.3.4.4 France: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.3.4.4.1 France: Europe Aquatic Veterinary Market Share - by Type
    - 13.3.4.4.2 France: Europe Aquatic Veterinary Market Share - by Diagnostic Type
    - 13.3.4.4.3 France: Europe Aquatic Veterinary Market Share - by Treatment Type
    - 13.3.4.4.4 France: Europe Aquatic Veterinary Market Share - by Species
    - 13.3.4.4.5 France: Europe Aquatic Veterinary Market Share - by Diseases Source
    - 13.3.4.4.6 France: Europe Aquatic Veterinary Market Share - by Route Of Administration
  - 13.4.5.5 Spain: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.4.5.5.1 Spain: Europe Aquatic Veterinary Market Share - by Type
    - 13.4.5.5.2 Spain: Europe Aquatic Veterinary Market Share - by Diagnostic Type
    - 13.4.5.5.3 Spain: Europe Aquatic Veterinary Market Share - by Treatment Type
    - 13.4.5.5.4 Spain: Europe Aquatic Veterinary Market Share - by Species
    - 13.4.5.5.5 Spain: Europe Aquatic Veterinary Market Share - by Diseases Source
    - 13.4.5.5.6 Spain: Europe Aquatic Veterinary Market Share - by Route Of Administration
  - 13.5.6.6 Italy: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.5.6.6.1 Italy: Europe Aquatic Veterinary Market Share - by Type
    - 13.5.6.6.2 Italy: Europe Aquatic Veterinary Market Share - by Diagnostic Type
    - 13.5.6.6.3 Italy: Europe Aquatic Veterinary Market Share - by Treatment Type
    - 13.5.6.6.4 Italy: Europe Aquatic Veterinary Market Share - by Species
    - 13.5.6.6.5 Italy: Europe Aquatic Veterinary Market Share - by Diseases Source
    - 13.5.6.6.6 Italy: Europe Aquatic Veterinary Market Share - by Route Of Administration
  - 13.6.7.7 Rest of Europe: Europe Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.6.7.7.1 Rest of Europe: Europe Aquatic Veterinary Market Share - by Type
    - 13.6.7.7.2 Rest of Europe: Europe Aquatic Veterinary Market Share - by Diagnostic Type
    - 13.6.7.7.3 Rest of Europe: Europe Aquatic Veterinary Market Share - by Treatment Type
    - 13.6.7.7.4 Rest of Europe: Europe Aquatic Veterinary Market Share - by Species
    - 13.6.7.7.5 Rest of Europe: Europe Aquatic Veterinary Market Share - by Diseases Source
    - 13.6.7.7.6 Rest of Europe: Europe Aquatic Veterinary Market Share - by Route Of Administration

14 Competitive Landscape

14.1 Heat Map Analysis by Key Players
14.2 Company Positioning & Concentration

15 Industry Landscape

15.1 Overview
15.2 New Product Development
15.3 Merger and Acquisition
15.4 Other Strategic Developments

16 COMPANY PROFILES

16.1 Thermo Fisher Scientific Inc
- 16.1.1 Key Facts
- 16.1.2 Business Description
- 16.1.3 Products and Services
- 16.1.4 Financial Overview
- 16.1.5 SWOT Analysis
- 16.1.6 Key Developments
16.2 Merck KGaA
- 16.2.1 Key Facts
- 16.2.2 Business Description
- 16.2.3 Products and Services
- 16.2.4 Financial Overview
- 16.2.5 SWOT Analysis
- 16.2.6 Key Developments
16.3 Zoetis Inc
- 16.3.1 Key Facts
- 16.3.2 Business Description
- 16.3.3 Products and Services
- 16.3.4 Financial Overview
- 16.3.5 SWOT Analysis
- 16.3.6 Key Developments
16.4 Virbac SA
- 16.4.1 Key Facts
- 16.4.2 Business Description
- 16.4.3 Products and Services
- 16.4.4 Financial Overview
- 16.4.5 SWOT Analysis
- 16.4.6 Key Developments
16.5 Phibro Animal Health Corp
- 16.5.1 Key Facts
- 16.5.2 Business Description
- 16.5.3 Products and Services
- 16.5.4 Financial Overview
- 16.5.5 SWOT Analysis
- 16.5.6 Key Developments
16.6 HIPRA SA
- 16.6.1 Key Facts
- 16.6.2 Business Description
- 16.6.3 Products and Services
- 16.6.4 Financial Overview
- 16.6.5 SWOT Analysis
- 16.6.6 Key Developments
16.7 Indian Immunologicals Ltd
- 16.7.1 Key Facts
- 16.7.2 Business Description
- 16.7.3 Products and Services
- 16.7.4 Financial Overview
- 16.7.5 SWOT Analysis
- 16.7.6 Key Developments
16.8 Esox Biologics Ltd
- 16.8.1 Key Facts
- 16.8.2 Business Description
- 16.8.3 Products and Services
- 16.8.4 Financial Overview
- 16.8.5 SWOT Analysis
- 16.8.6 Key Developments
16.9 Ceva Polchem Pvt Ltd
- 16.9.1 Key Facts
- 16.9.2 Business Description
- 16.9.3 Products and Services
- 16.9.4 Financial Overview
- 16.9.5 SWOT Analysis
- 16.9.6 Key Developments
16.10 Aquatic Diagnostics Ltd
- 16.10.1 Key Facts
- 16.10.2 Business Description
- 16.10.3 Products and Services
- 16.10.4 Financial Overview
- 16.10.5 SWOT Analysis
- 16.10.6 Key Developments

17. Appendix

17.1 About The Insight Partners